PDE6B and breast cancer: In the KM analysis of OS, high expressions of CANT1, CMPK1, DHODH, GMPS, RRM2B, and TXNRD1, and downregulation of PDE6B and POLR3GL were markedly associated with a poor prognosis of BC, further confirming the reliability of selected PMGs.